In conclusion, we found that our results demonstrated that AA protected against DOX-induced cardiomyopathy via activating AKT signaling, which restored Nrf2 activation and suppressed oxidative damage to improve cardiac function. The gene discussed is AKT1; the disease is cardiomyopathy.